» Articles » PMID: 17373178

Efficacy of Novel Skin Cream Containing Mixture of Human Growth Factors and Cytokines for Skin Rejuvenation

Overview
Specialty Dermatology
Date 2007 Mar 22
PMID 17373178
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The crucial role of growth factors and cytokines in cutaneous wound healing is well described, but there has been little investigation into their use for skin rejuvenation. A novel skin cream containing a mixture of human growth factors and cytokines was recently marketed for skin rejuvenation. The mixture was obtained through a biotechnology process using cultured human fetal skin cells, which originate from a dedicated cell bank originally established for the development of products in wound healing. The cream significantly reduced periorbital and perioral wrinkles, as well as improved skin texture of the chin after one month of treatment, which confirms the beneficial use of growth factors and cytokines for skin rejuvenation reported in 2 earlier studies. After 60 days of twice-daily application, 83% of the subject showed an improved average wrinkle score in the eye area, while 50% showed an improved average wrinkle score in the mouth area. In order to exclude a placebo effect, the efficacy of this product should be confirmed with a double-blind, randomized, placebo-controlled study. Also, the difference between mixtures of growth factor and cytokines should be further elaborated.

Citing Articles

A Comprehensive Review of Stem Cell Conditioned Media Role for Anti-Aging on Skin.

Alquraisy A, Wilar G, Mohammed A, El-Rayyes A, Suhandi C, Wathoni N Stem Cells Cloning. 2024; 17:5-19.

PMID: 39310304 PMC: 11416772. DOI: 10.2147/SCCAA.S480437.


Cosmeceuticals: The Principles and Practice of Skin Rejuvenation by Nonprescription Topical Therapy.

Glass G Aesthet Surg J Open Forum. 2023; 2(4):ojaa038.

PMID: 36776759 PMC: 9905273. DOI: 10.1093/asjof/ojaa038.


Back to the Cradle of Cytotherapy: Integrating a Century of Clinical Research and Biotechnology-Based Manufacturing for Modern Tissue-Specific Cellular Treatments in Switzerland.

Laurent A, Abdel-Sayed P, Scaletta C, Laurent P, Laurent E, Michetti M Bioengineering (Basel). 2021; 8(12).

PMID: 34940374 PMC: 8698568. DOI: 10.3390/bioengineering8120221.


Holistic Approach of Swiss Fetal Progenitor Cell Banking: Optimizing Safe and Sustainable Substrates for Regenerative Medicine and Biotechnology.

Laurent A, Hirt-Burri N, Scaletta C, Michetti M, de Buys Roessingh A, Raffoul W Front Bioeng Biotechnol. 2020; 8:557758.

PMID: 33195124 PMC: 7644790. DOI: 10.3389/fbioe.2020.557758.


Safety and Efficacy of a Novel Antiaging Skin Care Regimen Containing Neutraceuticals and Growth Factors on the Facial Skin of Women: A 12-Week Open-label Study.

Sadowski G, Sadowski J J Clin Aesthet Dermatol. 2020; 13(6):24-34.

PMID: 32884616 PMC: 7442306.